Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
about
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situEnergetics of the HIV gp120-CD4 binding reactionImmunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRComprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesHyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designThe human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts.Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV EnvHIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersα1Proteinase inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 diseaseHIV - 1 SUBTYPES, ITS IMPLICATIONS AND VIRAL DYNAMICS.Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoproteinFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesDefinition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomainMapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolateSelective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope.Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individualsDeterminants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies.Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.
P2860
Q21090535-21A82FEE-1A2D-47D7-9D86-629670283F01Q22254716-8B3E3313-4CC2-492E-83C8-DBD60AFE1D83Q24531479-D757F222-9457-4FA8-AF1D-F7EC4B4F96EFQ24541155-9B159E02-88E4-4A05-B14F-C410A2073B82Q24561905-A575BB53-A4E2-47CE-A457-01F1E039DA93Q24679395-79F152A3-35DA-4A69-A5FD-BFFFBA4ED08BQ27469663-537D7C54-3D5A-45CD-91B9-F7F7AEC0FCF4Q27469855-673B7688-2B08-4DB8-B072-EE5B8A91413CQ27472891-5E33EC5D-27BC-4437-AE9A-075624A4D883Q28256508-97C2E5A8-F440-4B5E-AB27-7831D32BABE9Q28647225-CD2446E7-0518-4D8A-ABB0-5CB5C016E2BBQ28731975-379B836F-A95F-4108-BBC6-E74B6C111BEBQ30390022-37994CAE-771F-4115-BA48-B8FE6E9DDD69Q30706865-3BDE77C4-3A71-4FDE-8E2E-BD84A35256EEQ31143293-85B96BEF-8D04-4ABF-8726-D817D262002DQ33522232-D630B402-0DAB-4A43-B8D4-EA4272A90472Q33587317-7308B4AF-A75C-4168-9FC0-6A24D6F0DDB9Q33683203-8A1274AC-25BA-45FF-A9B3-D7564F647929Q33782017-D58FA97B-BCC6-4084-B4AD-59618A0F3200Q33783829-C7B0EFE3-8810-487F-A7AB-84B4868ACFE0Q33784051-6A76946E-8B6C-4F8B-9DE1-518932D1E3CAQ33785510-1B12C784-4D5A-433D-9B86-E04D9CE66BF6Q33786049-C120F806-C6E7-482A-A67D-11E704926D6DQ33788874-5820E7B7-FBCB-4E72-9A6D-92907E212669Q33797964-22A8734A-EAD8-462B-9FF9-E68679567982Q33804811-49E50E74-C9C5-4A7E-9DB7-A6204D875C0BQ33809112-4A0EF359-CD5C-4F93-8F03-61898E2C3A5AQ33813526-ACB63737-14E3-42B5-8604-5F485E460EE3Q33821896-587C307F-F9F1-4F65-BD04-4F6C80E3AA80Q33823853-7E2DC8C7-81EE-4CEE-B2FF-5229A9384AB7Q33825418-570375BF-1E16-4D64-AF6C-52A6CA9D3E2CQ33826337-A4BFB347-4735-451F-9682-E4BEE5E5173DQ33835295-42E2CF98-8BC6-4394-BEBE-134E8F57F386Q33841935-C25C8E97-E793-45C8-A8A4-D9EF56C9E3B8Q33842152-5AC71A5A-B398-4E5B-BE2A-1D7FC7741ACEQ33848876-0A3A3932-8F47-4440-8899-1C487444E0C5Q33850605-0233D7B2-94FE-49FC-B0F8-144EEA03718AQ33850612-9E60EE50-FC18-4AB8-883B-62B0672AC154Q33851094-C36CEF42-3E5D-49DA-9347-A519211A1060Q33984296-7F7E9D38-DD17-4B74-B289-A8AC655CBB21
P2860
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Probing the structure of the h ...... anel of monoclonal antibodies.
@ast
Probing the structure of the h ...... anel of monoclonal antibodies.
@en
type
label
Probing the structure of the h ...... anel of monoclonal antibodies.
@ast
Probing the structure of the h ...... anel of monoclonal antibodies.
@en
prefLabel
Probing the structure of the h ...... anel of monoclonal antibodies.
@ast
Probing the structure of the h ...... anel of monoclonal antibodies.
@en
P2093
P2860
P1433
P1476
Probing the structure of the h ...... anel of monoclonal antibodies.
@en
P2093
J Sodroski
Q J Sattentau
P2860
P304
P407
P577
1994-01-01T00:00:00Z